Watch CBS News

FDA ALERT: Children's Robitussin And Dimetapp Cough Medicines Recalled Due To Overdose Risks

MINNEAPOLIS (WCCO) -- The U.S. Food and Drug Administration (FDA) has announced that two children's cough medicines have been recalled due to the risk of overdose.

According to the FDA, GSK Consumer Healthcare is voluntarily recalling two lots of Children's Robitussin® Honey Cough and Chest Congestion DM and one lot of Children's Dimetapp® Cold and Cough.

GSK Consumer Healthcare Issues Voluntary Nationwide Recall of Children's Robitussin® Honey Cough and Chest Congestion DM and Children's Dimetapp® Cold and Cough Due to Dosing Cups Missing Some Graduation Markings
(credit: FDA)

The medicine is being recalled due to dosing cups missing some graduation markings.

"There is a potential risk of accidental overdose if caregivers dispensing the syrup do not notice the discrepancies between the graduations printed on the dosing cups and the indicated amounts to be administered," the company said.

The FDA says the recalled lots were distributed across the United States between February 5, 2020, and June 3, 2020. The recalled lots include:

- Lots "02177" and "02178" for Children's Robitussin Honey Cough and Chest Congestion DM (4 ounces), expiring January 2022.
- Lot "CL8292" for Children's Dimetapp Cold and Cough (8 ounces), expiring September 2021.


Consumers with questions regarding the recall or to report any adverse experiences are asked to call 1-800-762-4675. The hours are 8 a.m. to 6 p.m. eastern time, Monday through Friday.

View CBS News In
CBS News App Open
Chrome Safari Continue
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.